Peter Palmer

2.7k citations
57 papers · 2.0k · 1 hit paper · h-index 18

Impact in

  • Hematology top 2%
    • Hematopoietic Stem Cell Transplantation
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research
    • Drug Transport and Resistance Mechanisms
    • Cancer Treatment and Pharmacology
    • Neutropenia and Cancer Infections

Papers in

    • Cancer Immunotherapy and Biomarkers 14
    • CAR-T cell therapy research 5
    • Drug Transport and Resistance Mechanisms 4
    • Immunotherapy and Immune Responses 7
    • Immune Cell Function and Interaction 6

Peter Palmer

53 papers receiving 1.9k citations

Peter Palmer's Hit Papers

An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy 1995 · 498 citations
4980+10+20Years since publication100200300400

Peers

Peter Palmer
Comparison fields: 5 of 86
  • Hematology 485
  • Oncology 883
  • Immunology 340
  • Genetics 111
  • Pathology and Forensic Medicine 148
Replace Judy H. Chiao with:
Judy H. Chiao United States
Robert J. Belt United States
Akos Czibere United States
Robert M. Rifkin United States
Arthur C. Louie United States
Sandrine Meyer‐Monard Switzerland
Michael Arbushites United States
Sen Hong Zhuang United States
Andrew J. Yee United States
Roger Chen United States
Peter Palmer relative to Judy H. Chiao United States Judy H. Chiao's profile →
Citations per field
00.5×1.5×
Judy H. Chiao · 1×
Citations per year

Countries citing papers authored by Peter Palmer

Since Specialization
Citations

This map shows the geographic impact of Peter Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Palmer more than expected).

Fields of papers citing papers by Peter Palmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Palmer. The network helps show where Peter Palmer may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Palmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Palmer Line = papers co-authored together Peter Palmer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#Work
1
An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy
Hit paper breakdown →
1995498
2 2004194
3 2003154
4 2002111
5 201996
6
The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel.
200083
7 198868
8 199361
9 199256
10 200254
11 199347
12 199147
13 200542
14
A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.
200340
15 199137
16 199029
17 199427
18 199419
19 199417
20 199117

About Peter Palmer

Peter Palmer is a scholar working on Oncology, Immunology, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 57 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (5 papers), Bladder and Urothelial Cancer Treatments (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Hematology (485 citations), Oncology (883 citations), Immunology (340 citations), Genetics (111 citations) and Pathology and Forensic Medicine (148 citations). Peter Palmer has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Cathy Allen, C H Weaver, Lee S. Schwartzberg, Robert Birch, B Hazelton, W. H. West, Juan José Pérez Ruixo, C.R. Franks, C.J. Bol and R. Oskam. Their work appears in journals such as Cancer Treatment Reviews, European Journal of Cancer, Journal of Clinical Oncology, Cancer and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact